HUT40699A - Surface antigen of hepatitis b prepared by recombinant dna technique, vaccines, diagnostics, cell lines and process for preparing thereof - Google Patents
Surface antigen of hepatitis b prepared by recombinant dna technique, vaccines, diagnostics, cell lines and process for preparing thereofInfo
- Publication number
- HUT40699A HUT40699A HU861577A HU157786A HUT40699A HU T40699 A HUT40699 A HU T40699A HU 861577 A HU861577 A HU 861577A HU 157786 A HU157786 A HU 157786A HU T40699 A HUT40699 A HU T40699A
- Authority
- HU
- Hungary
- Prior art keywords
- vaccines
- diagnostics
- hepatitis
- preparing
- prepared
- Prior art date
Links
- 108020004511 Recombinant DNA Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
- G01N33/5764—Hepatitis B surface antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP85104521 | 1985-04-15 | ||
US85056786A | 1986-04-11 | 1986-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUT40699A true HUT40699A (en) | 1987-01-28 |
Family
ID=26096680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU861577A HUT40699A (en) | 1985-04-15 | 1986-04-15 | Surface antigen of hepatitis b prepared by recombinant dna technique, vaccines, diagnostics, cell lines and process for preparing thereof |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR960004264B1 (en) |
AU (1) | AU606574B2 (en) |
DK (1) | DK171386A (en) |
FI (1) | FI95045C (en) |
HU (1) | HUT40699A (en) |
NO (1) | NO861450L (en) |
NZ (1) | NZ215820A (en) |
OA (1) | OA08238A (en) |
PT (1) | PT82392B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988010301A1 (en) * | 1987-06-22 | 1988-12-29 | Mccormick And Jones Engineering Ltd. | Hepatitis b surface antigen vaccine |
-
1986
- 1986-04-14 NZ NZ215820A patent/NZ215820A/en unknown
- 1986-04-14 FI FI861559A patent/FI95045C/en not_active IP Right Cessation
- 1986-04-14 NO NO861450A patent/NO861450L/en unknown
- 1986-04-15 PT PT82392A patent/PT82392B/en not_active IP Right Cessation
- 1986-04-15 OA OA58835A patent/OA08238A/en unknown
- 1986-04-15 HU HU861577A patent/HUT40699A/en unknown
- 1986-04-15 AU AU56114/86A patent/AU606574B2/en not_active Ceased
- 1986-04-15 KR KR1019860002859A patent/KR960004264B1/en not_active IP Right Cessation
- 1986-04-15 DK DK171386A patent/DK171386A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI95045C (en) | 1995-12-11 |
KR860008284A (en) | 1986-11-14 |
PT82392B (en) | 1988-03-03 |
FI95045B (en) | 1995-08-31 |
AU606574B2 (en) | 1991-02-14 |
FI861559A0 (en) | 1986-04-14 |
AU5611486A (en) | 1986-10-23 |
DK171386D0 (en) | 1986-04-15 |
PT82392A (en) | 1986-05-01 |
FI861559A (en) | 1986-10-16 |
DK171386A (en) | 1986-10-16 |
NZ215820A (en) | 1989-01-06 |
OA08238A (en) | 1987-10-30 |
NO861450L (en) | 1986-10-16 |
KR960004264B1 (en) | 1996-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL78472A0 (en) | Hepatitis b surface antigen formed by recombinant dna techniques,vaccines,diagnostics,cell lines and methods of forming same | |
PH25249A (en) | Method for producing hepatitis b virus proteins in yeast | |
HU9502949D0 (en) | Polipeptides, polinucleotides, vectors and host cells, and vaccines against hepatitis virus infection, diagnostics, immunoassay and culturing methods | |
DE3176404D1 (en) | Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine | |
HK102595A (en) | Hepatitis delta diagnostics and vaccines, their preparation and use | |
LTIP1793A (en) | Method for detecting antibodies against hiv virus | |
AP8800078A0 (en) | Hepatitis b virus surface antigens and hybrid antigens containing them | |
PT75643B (en) | Method for preparing dna,recombinant dna hosts containing them and polipeptides | |
IL70947A (en) | Synthetic polypeptides from viral oncogenes,antigens,diagnostic reagents and vaccines including them,and method for using same for detecting diseases | |
IL69423A0 (en) | Recombinant plasmid inserted with hepatitis b virus gene,yeast transformed with said recombinant plasmid and production of hepatitis b virus surface antigen | |
EP0105149A3 (en) | Recombinant plasmid containing hepatitis b virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis b virus surface antigen | |
ZA861767B (en) | Process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic | |
IL78874A0 (en) | Method of preparing vaccines and process for the production thereof | |
YU18186A (en) | Process for obtaining polypeptides which can be used for vaccine | |
DE3160264D1 (en) | Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines | |
HK140095A (en) | Hepatitis surface antigen particle vaccine | |
EP0232410A4 (en) | Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells. | |
ZA894182B (en) | Method for producing nonhyperglycosylated hepatitis b virus proteins | |
HUT40699A (en) | Surface antigen of hepatitis b prepared by recombinant dna technique, vaccines, diagnostics, cell lines and process for preparing thereof | |
PT80051A (en) | Process for preparing recombinant dna expression vectors and method for gene expression | |
ZA878303B (en) | A process for isolating and characterizing a new viral agent and its associated antigen,the antigen and viral agent obtained by this process,and detection procedures for non a,non b hepatitis using suitable immunological reagents | |
GB2181434A (en) | Hepatitis b virus vaccine and process for its preparation | |
DE3666666D1 (en) | Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same | |
IL83670A0 (en) | Dna coding for antigen protein of rinderpest virus and process for the preparation thereof | |
ZA868611B (en) | Fermentation methods for hepatitis vaccine production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |